Prolonged duration of lymphocyte deficiency, high-grade CRS, and ventilation are linked to fungal breakthrough in patients with hematologic malignancies 60 days after CAR-T infusion: A single center case-control study
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine
Reference41 articles.
1. TCR engineered T cells for solid tumor immunotherapy;Zhang;Exp Hematol Oncol,2022
2. Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper;Los-Arcos;Infection,2020
3. Incidence and risk factors associated with infection after chimeric antigen receptor T cell therapy for relapsed/refractory B-cell malignancies;Zhu;Cell Transpl,2021
4. Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells;Park;Clin Infect Dis,2018
5. Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma;Wudhikarn;Blood Cancer J,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Invasive Fungal Disease in Immunocompromised Children: Current and Emerging Therapies;Current Infectious Disease Reports;2024-08-31
2. A comprehensive review on the role of T cell subsets and CAR-T cell therapy in Aspergillus fumigatus infection;Human Immunology;2024-03
3. Invasive fungal infections in patients with multiple myeloma: a possible growing problem in hematology and infectious diseases;Therapeutic Advances in Infectious Disease;2024-01
4. Invasive Fungal Diseases;The EBMT Handbook;2024
5. CRO infection and the Use of MRSA-active Medication for Prophylaxis affect the Prognosis of Patients with Hematological Malignancies after CAR-T Infusion;International Journal of Antimicrobial Agents;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3